A new nomogram for estimating the change in probability of recovering erectile function and continence after radical prostatectomy has been proposed based on retrospective analysis of a ...

SAN ANTONIO -- More than 2 years after treatment, no patient with high-risk prostate cancer had a confirmed biochemical recurrence after receiving postoperative apalutamide (Erleada) and androgen ...